Publicaciones en colaboración con investigadores/as de Universidad de Salamanca (24)

2019

  1. La medicina clínica en la universidad de Salamanca

    Evolución de la medicina en los últimos cincuenta años (1968-2018): Homenaje a la Universidad de Salamanca en su 800 aniversario (Los cuadernos del castor), pp. 283-296

2012

  1. Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes

    European Journal of Clinical Investigation, Vol. 42, Núm. 5, pp. 548-556

2010

  1. Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients

    BMC Medicine, Vol. 8

2009

  1. An association between resistant hypertension and the null GSTM1 genotype

    Journal of Human Hypertension, Vol. 23, Núm. 8, pp. 556-558

  2. Association between -T786C NOS3 polymorphism and resistant hypertension: A prospective cohort study

    BMC Cardiovascular Disorders, Vol. 9

  3. Effect of different antihypertensive treatments on Ras, MAPK and Akt activation in hypertension and diabetes

    Clinical Science, Vol. 116, Núm. 2, pp. 165-173

2008

  1. Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction: Molecular Diagnosis

    Journal of Cellular and Molecular Medicine, Vol. 12, Núm. 3, pp. 955-961

2007

  1. Long-term nebivolol administration reduces renal fibrosis and prevents endothelial dysfunction in rats with hypertension induced by renal mass reduction

    Journal of Hypertension, Vol. 25, Núm. 12, pp. 2486-2496

2005

  1. Relationships between NOS2 and HO-1 in liver of rats with chronic bile duct ligation

    Hepatology Research, Vol. 32, Núm. 1, pp. 58-65

2004

  1. Sequential changes in redox status and nitric oxide synthases expression in the liver after bile duct ligation

    Life Sciences, Vol. 75, Núm. 6, pp. 717-732

2001

  1. Endoglin expression in human and rat mesangial cells and its upregulation by TGF-β1

    Biochemical and Biophysical Research Communications, Vol. 282, Núm. 1, pp. 142-147

1999

  1. Antiphosphatidylserine antibodies in patients with autoimmune diseases and HIV-infected patients: Effects of Tween 20 and relationship with antibodies to β2-glycoprotein I

    Journal of Clinical Laboratory Analysis, Vol. 13, Núm. 2, pp. 59-64

  2. Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation

    Clinical Science, Vol. 96, Núm. 3, pp. 297-305

  3. Interaction between prostanoids and nitric oxide in the control of tubular function in rats with chronic bile duct ligation

    Canadian Journal of Physiology and Pharmacology, Vol. 77, Núm. 2, pp. 111-117

1998

  1. Increased nitric oxide synthesis and inducible nitric oxide synthase expression in patients with alcoholic and non-alcoholic liver cirrhosis

    Clinical Science, Vol. 94, Núm. 6, pp. 637-643

1997

  1. Elevated glomerular and blood mononuclear lymphocyte nitric oxide production in rats with chronic bile duct ligation: Role of inducible nitric oxide synthase activation

    Hepatology, Vol. 26, Núm. 2, pp. 268-276

1996

  1. Correlation among endoscopic, histological, and microbiological findings in gastroduodenal pathology associated with Helicobacter pylori

    Anales de medicina interna (Madrid, Spain : 1984), Vol. 13, Núm. 6, pp. 269-273

  2. Diverticulo esofagico epifrenico

    Prensa Medica Argentina, Vol. 83, Núm. 5, pp. 467-470

1995

  1. Nitric oxide production by mononuclear leukocytes in alcoholic cirrhosis

    Journal of Molecular Medicine, Vol. 73, Núm. 1, pp. 31-33

1993

  1. Detection and clinical course of metabolic multiple vascular risk syndrome

    Anales de medicina interna (Madrid, Spain : 1984), Vol. 10, Núm. 8, pp. 369-376